The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
Patients must be informed of the experimental nature of the study and its potential risks, and must sign an Institutional Review Board (IRB)-approved written informed consent form indicating such an understanding
The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
Subject must be able to give written Institutional Review Board (IRB) approved informed consent and be able to follow protocol requirements
Understand and sign an Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved informed consent form (ICF) prior to any study-specific evaluation
INCLUSION CRITERIA FOR SECOND-LINE THERAPY: Subject is capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consent, approved by the Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
Subjects must be competent to comprehend, provide written informed consent, and date an independent ethics committee/institutional review board/research ethics board (IEC/IRB/REB) approved informed consent form
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document and follow study procedures including willingness to undergo study biopsies
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Signed written Institutional Review Board (IRB)-approved informed consent document
Subject must be fully informed about their illness and the investigational nature of the study protocol (including foreseeable risks and possible side effects) and must sign and date an IRB [Institutional Review Board]-approved Informed consent Form [ICF] (including Health Insurance Portability and Accountability Act authorization, if applicable) before performance of any study specific procedures or tests.
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Patients must be able to understand and agree to sign an institutional review board (IRB)-approved informed consent form
Patients must give IRB approved, study specific, informed consent.
Able to understand and has provided written informed consent. A legally authorized representative may consent on behalf of a subject who is otherwise unable to provide informed consent, if acceptable to and approved by the site and/or site's Institutional Review Board (IRB)/Independent Ethics Committee (IEC).
Subjects must be willing to sign and provide informed consent and be capable of giving informed consent in accordance with the Institutional Review Board/Ethics Committee policy
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and willingness to sign Institutional Review Board (IRB)-approved informed consent
Participant or legal representative must understand the investigational nature of this study and sign an Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and the willingness to sign a written informed consent document that is approved by the local institutional review board
Patient understands the study regimen, its requirements, risks and discomforts and is able and willing to sign the informed consent form; voluntary signed and dated Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written informed consent form in accordance with regulatory and institutional guidelines must be obtained before the performance of any protocol related procedures that are not part of normal patient care; subjects must be competent to report adverse events (AEs), understand the drug dosing schedule and use of medications to control AEs
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Able to and provides Institutional Review Board (IRB) approved study specific written informed consent
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Eligible and consent to the Institutional Review Board (IRB) 13-0002 registry trial protocol
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Informed consent: All patients or their legal guardians (if the patient is <18 years of age) must sign an Ethics or institutional Review Board approved consent form indicating their awareness of the investigational nature and the risks of this study. When appropriate, younger patients will be included in all discussions in order to obtain assent.
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Patients must sign IRB approved study specific informed consent.
Patients must sign Institutional Review Board (IRB) approved study specific informed consent
Patients must have signed and dated an Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved written informed consent form (ICF) in accordance with regulatory and institutional guidelines; this must be obtained before the performance of any protocol related procedures that are not part of normal patient care
Is willing and able to provide written informed consent for the trial and has signed the appropriate written informed consent form, approved by the investigator’s Institutional Review Board (IRB)/Independent Ethics Committee (IEC), prior to the performance of any trial activities.
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document
Ability to understand and provide signed informed consent that fulfills institutional review board (IRB)’s guidelines
Is willing to voluntarily sign and date an informed consent form that is approved by an institutional review board before the conduct of any study procedure
All subjects must have the ability to understand and the willingness to sign a written informed consent; signed informed consent form approved by the Institutional Review Board (IRB) is required; the patient, family member, and transplant staff physician (physician, nurse, and social worker) meet at least once prior to starting the transplant procedure; during this meeting, all pertinent information with respect to risks and benefits to the donor and recipient will be presented; alternative treatment modalities will be discussed
Subject must voluntarily sign and date an informed consent, approved by an Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and willingness to sign an institutional review board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Able to understand and willingness to provide informed consent, and the willingness to comply with the requirements of the protocol\r\n* Subjects must have signed and dated an Institutional Review Board (IRB)/Independent Ethics Committees (IEC) approved written informed consent form in accordance with regulatory and institutional guidelines and before the performance of any protocol related procedures that are not part of standard of care
Participants must be able to give self-consent and then sign and date an Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved written informed consent in accordance with local regulatory and institutional guidelines; this consent must be obtained before the performance of any protocol-related procedures that are not considered part of normal participant care
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Competent to comprehend, sign, and date an independent ethics committee/institutional review board/research ethics board (IEC/IRB/REB) approved informed consent form
Ability to understand and the willingness to sign an Institutional Review Board (IRB) approved written informed consent document
Able to understand and willing to sign an informed consent form. A legally authorized representative may consent on behalf of a subject who is otherwise unable to provide informed consent, if acceptable to, and approved by, the site's Institutional Review Board (IRB)/Independent Ethics Committee (IEC).
Participant must voluntarily sign and date an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Patients must be informed of the experimental nature of the study and its potential risks, and must sign an Institutional Review Board (IRB)-approved written informed consent form indicating such an understanding
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Signed informed consent approved by the Institutional Review Board
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Subjects must have signed and dated an Institutional Review Board/Independent Ethics Committee (IRB/IEC) approved written informed consent form in accordance with regulatory and institutional guidelines. This must be obtained before the performance of any protocol related procedures that are not part of normal subject care.
Willing to sign consent onto the Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking study, Institutional Review Board (IRB) number 15-000136 (blood draw optional)
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Subject is capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consent, approved by the Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent
have read, understood and signed the informed consent form (ICF) approved by the Institutional Review Board (IRB);
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Ability to understand and the willingness to sign an institutional review board (IRB)-approved informed consent document
Signed an institutional review board (IRB)-approved informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
Individuals able to understand and willing to sign an Institutional Review Board (IRB)-approved informed consent document
Patients must also provide written consent for biospecimens collection on Institutional Review Board (IRB) 08-000980
Written informed consent to participate in the study according to the investigational review board (IRB)
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Subjects must have signed and dated an Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written informed consent form in accordance with regulatory and institutional guidelines; this must be obtained before the performance of any protocol related procedures that are not part of normal subject care
Must be fully informed regarding their illness and the investigational nature of the study protocol, and must sign an Institutional Review Board (IRB) approved Informed Consent Form (ICF).
Subjects must have signed and dated an Institutional Review Board/Independent Ethics Committee (IRB/IEC) approved written informed consent form in accordance with regulatory and institutional guidelines; this must be obtained before the performance of any protocol related procedures that are not part of normal subject care
Participant must voluntarily sign and date an informed consent form, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Voluntarily sign and date an informed consent form (ICF) with authorization to use protected health information (in accordance with national and local subject privacy regulations) and approved by the Institutional Review Board (IRB) prior to initiation of any study specific procedures
A signed informed consent form approved by the Duke University Institutional Review Board (IRB) will be required for patient enrollment into the study; patients (if 18 years old) or their parent(s) or guardian(s) must be able to read and understand the informed consent document and must sign the informed consent indicating that they are aware of the investigational nature of this study; all children will have to provide assent to the study
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator’s Institutional Review Board (IRB)/Ethics Committee
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
All patients must sign informed consent verifying that they are aware of the investigational nature of this study in keeping with the rules and policies of MD Anderson Cancer Center; the only acceptable consent is the one approved by MD Anderson Institutional Review Board (IRB)
Ability to understand and the willingness to sign a written informed consent document that is approved by the local institutional review board and Health Insurance Portability and Accountability Act (HIPAA) authorization for the release of personal health information
Patient must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator’s Institutional Review Board (IRB)/Ethics Committee
A signed informed consent form approved by the Institutional Review Board (IRB) will be required for patient enrollment into the study; patients must be able to read and understand the informed consent document and must sign the informed consent indicating that they are aware of the investigational nature of this study
Patient is capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consent, approved by the Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
Subjects must have signed and dated an Institutional Review Board (IRB)-approved written informed consent form in accordance with regulatory and institutional guidelines; this must be obtained before the performance of any protocol-related procedures that are not part of normal subject care
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Able to understand and willing to sign an Institutional Review Board (IRB) approved, written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Voluntary signed and dated Institutional Review Board (IRB) approved informed consent form in accordance with regulatory and institutional guidelines
Written consent on an Institutional Review Board-approved informed consent form prior to any study-specific evaluation
All subjects must have the ability to understand and the willingness to sign a written informed consent that has been approved by the City of Hope Institutional Review Board (COH IRB); the patient, a family member and transplant staff physician (physician, nurse, social worker) will meet at least once prior to the subject signing consent; during this meeting all pertinent information with respect to risks and benefits to donor and recipient will be presented; alternative treatment modalities will be discussed; the risks are explained in detail in the enclosed consent form
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Ability to understand the purposes and risks of the study and has signed a written consent form approved by the investigator’s Institutional Review Board (IRB)/ethics committee
Study-specific informed consent approved for this purpose by the Institutional Review Board (IRB) of the University of Michigan indicating that they are aware of the investigational nature of the treatment and the potential risks must be signed by the patient
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Patients must sign the Institutional Review Board (IRB)-approved informed consent document for this trial
Voluntary signed and dated Institutional Review Board (IRB) approved informed consent form in accordance with regulatory and institutional guidelines
Able to understand and willing to sign an institutional review board (IRB) approved written informed consent document
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Able to understand and willing to sign an institutional review board (IRB)-approved written informed consent document (legally authorized representative permitted)
All patients must sign informed consent forms verifying that they are aware of the investigational nature of this study in keeping with the rules and policies of MD Anderson Cancer Center; the only acceptable consent form is one approved by the MD Anderson institutional review board
Be able to give written Institutional Review Board (IRB) approved informed consent and be able to follow protocol requirements
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and provide signed informed consent that fulfills Institutional Review Board (IRB) guidelines
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Signed informed consent approved by the Institutional Review Board
Patient must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
DONOR: Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Patient or durable power of attorney (DPA) for healthcare must be able to understand and voluntarily sign an Institutional Review Board (IRB) -approved informed consent form
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Patients must have signed and dated an Institutional Review Board (IRB) approved written informed consent form in accordance with regulatory and institutional guidelines; this must be obtained before the performance of any protocol related procedures that are not part of normal subject care
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Patient is unwilling or unable to sign and date the Institutional Review Board (IRB) approved informed consent
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Subjects must sign and date an Institutional Review Board-approved informed consent form (including Health Insurance Portability and Accountability Act authorization, if applicable) before performance of any study-specific procedures or tests
Signed informed consent approved by the Institutional Review Board prior to patient entry
Patients must be informed of the experimental nature of the study and its potential risks, and must sign an Institutional Review Board (IRB)-approved written informed consent form indicating such an understanding
Signed informed consent approved by the Institutional Review Board prior to patient entry
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Understand and voluntarily sign an Institutional Review Board (IRB)-approved informed consent form
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Patients must voluntarily provide written Institutional Review Board (IRB)-approved informed consent
Sign an Institutional Review Board (IRB)-approved informed consent document
Ability to understand and willingness to sign an institutional review board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
All patients must sign an Institutional Review Board (IRB)-approved informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Subject must sign and date an Institutional Review Board-approved informed consent form (including Health Insurance Portability and Accountability Act authorization, if applicable) before performance of any study-specific procedures or tests.
The patient or, if applicable, her legally authorized representative must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
Patients will sign an Institutional Review Board (IRB)-approved informed consent form prior to any study-related procedures
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Patient understands the study regimen, its requirements, risks and discomforts and is able and willing to sign the informed consent form; voluntary signed and dated Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written informed consent form in accordance with regulatory and institutional guidelines must be obtained before the performance of any protocol related procedures that are not part of normal patient care
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's IRB/Ethics Committee
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator’s Institutional Review Board (IRB)/Ethics Committee
Signed informed consent approved by the Institutional Review Board
Mentally competent, ability to understand and willingness to sign an Institutional Review Board (IRB)-approved written informed consent form
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Relapsed/refractory MCL: Understand and voluntarily sign an Institutional Review Board (IRB)-approved informed consent form
Newly diagnosed MCL: Understand and voluntarily sign an IRB-approved informed consent form
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved written informed consent document
The subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent prior to receiving any study related procedure
Patients must be able to understand and agree to sign an Institutional Review Board (IRB)-approved informed consent form
All patients must sign an Institutional Review Board (IRB)-approved informed consent document
Understanding and voluntarily signing an Institutional Review Board (IRB)-approved informed consent form
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Voluntary signed Institutional Review Board (IRB)-approved informed consent before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care
All patients must sign informed consent verifying that they are aware of the investigational nature of this study in keeping with the rules and policies of M.D. Anderson Cancer Center; the only acceptable consent form is the one attached at the end of this protocol, and it must have been approved and amended by the M.D. Anderson Institutional Review Board (IRB)
All patients must sign an informed consent approved by the Institutional Review Board indicating that they are aware of the investigational nature of this study; patients must sign an authorization for the release of their protected health information
Subject is capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consent, approved by the Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
Co-enrollment on Institutional Review Board (IRB) #98117, entitled Molecular Pathogenesis of Therapy-Related Leukemia, Dr. Armenian, principal investigator
Written informed consent and/or Consent waiver by institutional review board (IRB)
Institutional Review Board (IRB)-/Independent Ethics Committee (IEC)-approved written Informed Consent and privacy language as per national regulations must be obtained from the subject or legally authorized representative prior to any study-related procedures
Institutional Review Board (IRB)-approved informed consent obtained and signed
Patients must sign the current institutional review board (IRB) approved informed consent indicating that they are aware of the investigational nature of this study, in keeping with the policies of the institution, and willing and able to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
All patients must sign an institutional review board (IRB)-approved informed consent document
Subjects must give institutional review board (IRB)-approved study-specific informed consent
Understand and sign, written Institutional Review Board (IRB)-approved informed consent form, and be willing to comply with all study procedures
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Patients must have signed informed consent both for this study and the research use of data in the UAB bone marrow transplantation (BMT) program's Institutional Review Board (IRB) registered clinical database
Signed and dated institutional review board (IRB)/independent ethics committee (IEC)-approved informed consent form (ICF) before any study specific screening procedures are performed
The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document (either directly or via a legally authorized representative)
Patients must be able to understand and agree to sign an Institutional Review Board (IRB)-approved informed consent form
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Able to understand and willing to sign an institutional review board (IRB) approved written informed consent document
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable).
Subject is capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consents, approved by the Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
FOR TISSUE COLLECTION TO ESTABLISH PDX (PART 1): Understand and voluntarily sign an Institutional Review Board (IRB)-approved informed consent form.
Ability to understand and willingness to sign an institutional review board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable).
Participant is capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to initiation of any screening or study-specific procedures
Signed, written Institutional Review Board (IRB)-approved informed consent form (ICF)
The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Participants must have signed and dated an Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved written informed consent form in accordance with regulatory and institutional guidelines; this must be obtained before the performance of any protocol-related procedures that are not part of normal patient care
All patients or their legal guardians (if the patient is < 18 years old) must sign an Institutional Review Board (IRB)-approved document of informed consent to demonstrate their understanding of the investigational nature and the risks of this study before any protocol-related studies are performed; when appropriate, pediatric subjects will be included in all discussions
Ability to understand and the willingness to sign a written Institutional Review Board (IRB)-approved informed consent document
Patients must understand and be willing to sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Michigan Medical Center indicating that they are aware of the investigational aspects of the treatment and the potential risks
DONOR: The donor or legal guardian greater than 18 years of age, capable of signing an Institutional Review Board (IRB)-approved consent form
Able to understand and willing to sign an institutional review board (IRB)-approved written informed consent document
All patients must be informed about the study and have signed a current Institutional Review Board (IRB) approved informed consent
Subject is capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consent, approved by the Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
Provide voluntary written consent and Health Insurance Portability and Accountability Act (HIPAA) authorization for release of personal health information, approved by an Institutional Review Board/Independent Ethics Committee (IRB/IEC)
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Informed consent: all subjects must have the ability to understand and the willingness to sign an Institutional Review Board (IRB) approved consent form
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving and study related procedure
All patients or their legal representative (for patients < 18 years old) must sign an Institutional Review Board (IRB) approved informed consent document (cGVHD natural history protocol 04-C-0281 or any National Cancer Institute [NCI] protocol allowing for screening procedures) prior to performing studies to determine patient eligibility; after confirmation of patient eligibility all patients or their legal representative must sign the protocol specific informed consent; for pediatric patients age appropriate assent will be obtained in accordance with NIH guidelines
Patient (or legally authorized representative if applicable) must be able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Understand and sign an IRB/IEC-approved ICF prior to any study-specific evaluation
Provision of written informed consent approved by the Institutional Review Board (IRB) or Independent Ethics Committee (IEC) with privacy language in accordance with national regulations (e.g., Health Insurance Portability and Accountability Act [HIPAA] authorization for United States [US] sites) prior to any study related procedures, including withdrawal of prohibited medications if applicable.
Ability to understand and sign an Independent Ethics Committee- or Institutional Review Board-approved informed consent document indicating that the subject (or legally acceptable representative) has been informed of all aspects of the trial and is willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures. The informed consent document must be signed prior to the subject undergoing tests or procedures solely for determining study eligibility and prior to receiving any protocol treatment.
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Subjects who voluntarily signed and dated Institutional Review Board approved informed consent form in accordance with regulatory and institutional guidelines. Hepatocellular Carcinoma Inclusion Criteria:
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Understanding and voluntary signing an institutional review board (IRB)-approved informed consent form
Patients must be informed of the experimental nature of the study and its potential risks and must sign an Institutional Review Board (IRB)-approved written informed consent form indicating such an understanding
Able to understand and willing to sign Institutional Review Board (IRB)-approved written informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (legally authorized representative is allowed)
Patients must exercise informed voluntary consent and sign a consent form approved by the University of Minnesota Institutional Review Board (IRB): Human Subjects Committee
Ability to understand and provide signed informed consent that fulfills Institutional Review Board (IRB)’s guidelines
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Able to understand and sign the Institutional Review Board (IRB)-approved informed consent document for this trial
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document
Ability to understand and willingness to sign an institutional review board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Able to understand and be willing to sign an Institutional Review Board (IRB) approved written informed consent document (or legally authorized representative, if applicable)
Has read, understood and signed the informed consent form (ICF) approved by the Institutional Review Board/Independent Ethics Committee (IRB/IEC).
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Participant or legal representative must understand the investigational nature of this study and sign an independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Subjects must have signed and dated an Institutional Review Board (IRB)/Institutional Ethics Committee (IEC) approved written informed consent form in accordance with regulatory and institutional guidelines; this must be obtained before the performance of any protocol related procedures that are not part of normal subject care
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Signed informed consent approved by the Institutional Review Board
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Provided written informed consent and HIPAA authorization for release of personal health information, approved by an Institutional Review Board/Independent Ethics Committee (IRB/IEC).
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's Institutional Review Board (IRB)/Ethics Committee
Subject must voluntarily sign and date an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Understand and voluntarily sign an institutional review board (IRB)-approved informed consent form
Able to understand and willing to sign an Institutional Review Board (IRB)-approved informed consent document
Subject must be able to understand and willing to sign an informed consent. A legally authorized representative may consent on behalf of a subject who is otherwise unable to provide informed consent, if acceptable to and approved by the site and/or site's Institutional Review Board (IRB).
Subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and the willingness to sign a written informed consent document that is approved by an institutional review board
Signed and dated institutional review board (IRB)/independent ethics committee (IEC)-approved informed consent form (ICF) before any study specific screening procedures are performed
Signed an informed consent document that has been approved by an institutional review board or independent ethics committee (IRB/IEC).
Mentally competent, ability to understand and willingness to sign an Institutional Review Board (IRB)-approved written informed consent form
Written informed consent to participate in the study according to the Investigational Review Board (IRB)
Subjects must be able to understand and willing to sign an informed consent. A legally authorized representative may consent on behalf of a subject who is otherwise unable to provide informed consent, if acceptable to and approved by the site and/or sites Institutional Review Board (IRB)/Independent Ethics Committee (IEC).
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and willingness to sign a written informed consent document (approved by Institutional Review Board or independent ethics committee) obtained prior to any study procedure, with the understanding that the subject may withdraw at any time without prejudice
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document (legally authorized representative permitted)
Signed, Institutional Review Board (IRB)-approved written informed consent
All patients must sign informed consent verifying that they are aware of the investigational nature of this study in keeping with the rules and policies of MD Anderson Cancer Center; the only acceptable consent form is the one approved by MD Anderson institutional review board (IRB)
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Participants must sign the most current institutional review board (IRB)-approved study informed consent form (ICF)
Subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Signed informed consent approved by the Institutional Review Board prior to patient entry
Signed informed consent approved by the Institutional Review Board prior to patient entry
Understand and voluntarily sign an Institutional Review Board (IRB)-approved informed consent form
Sign an institutional review board (IRB)-approved informed consent document
Patient must be able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Patients must be informed of the experimental nature of the study and its potential risks, and must sign an Institutional Review Board (IRB)-approved written informed consent form indicating such an understanding
Patient must be able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Patient (or legally authorized representative if applicable) must be able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Signed an Institutional Review Board (IRB)-approved informed consent document for this protocol
Voluntarily signed Institutional Review Board (IRB) approved informed consent document (ICD) before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care.
Signed an institutional review board (IRB)-approved informed consent document for this protocol
Ability to understand and the willingness to sign a written informed-consent document that is approved by the local institutional review board
Patient must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Subject is capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consent, approved by the Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
A signed informed consent form approved by the Duke University Institutional Review Board (IRB) will be required for patient enrollment into the study; patients must be able to read and understand the informed consent document and must sign the informed consent indicating that they are aware of the investigational nature of this study
Optional participation in the microdose imaging trial, Institutional Review Board (IRB)#10-139
Patients must be informed of the experimental nature of the study and its potential risks and must sign an institutional review board (IRB)-approved written informed consent form indicating such an understanding
E 14. Absence of signed and dated Institutional Review Board (IRB)-approved participant informed consent form prior to enrollment into the study.
Signed, Institutional Review Board (IRB)-approved written informed consent
Signed, Institutional Review Board (IRB)-approved written informed consent
Sign the current Institutional Review Board (IRB) approved informed consent indicating that they are aware of the investigational nature of this study, in keeping with the policies of the institution
All patients must sign and informed consent approved by the Institutional Review Board indicating that they are aware of the investigational nature of this study; patients must also sign an authorization for the release of their protected heath information
Subject or legally authorized representative of a subject must provide signed informed consent document that has been approved by an Institutional Review Board or Independent Ethics Committee (IRB/IEC) prior to initiation of any study-related tests or procedures that are not part of standard-of-care for the subject’s disease
Ability to understand and provide signed informed consent approved by the Institutional Review Board prior to any study-related activities and within 30 days of first study dose
Written informed consent to participate in the study according to the investigational review board (IRB) or independent ethics committee (IEC)
Patients must agree to randomization as documented by signing the Institutional Review Board (IRB) approved consent form
Patients must sign informed consent indicating that they are aware of the investigational nature of this study according to the policies of the MD Anderson Cancer Center (MDACC) Institutional Review Board (IRB)
Patients or a legal guardian will sign an informed consent form approved by the Institutional Review Board (IRB) and obtained by the principal or a co-investigator before patient entry; minors will provide assent
All patients or their legal guardians (if the patients is < 18 years old) must sign an institutional review board (IRB) approved document of informed consent indicating their understanding of the investigational nature and the risks of this study BEFORE any protocol related studies are performed (this does not include routine laboratory tests or imaging studies required to establish eligibility); when appropriate, pediatric patients will be included in all discussion in order to obtain verbal assent
Competent to comprehend, sign, and date an IRB-approved informed consent form
Subject is capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consent, approved by the Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
This study must be evaluated and confirmed by the local ethics committees and institutional review board of the participating institution, in accordance to the declaration of Helsinki; informed consent must be administered and the parent or guardian must sign the document, authorized by the Ethics Committee and human subjects (therapy cannot start if the documents is not signed)
Signed written informed consent\r\n* Subjects must have signed and dated an Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved written informed consent form in accordance with regulatory and institutional guidelines; this must be obtained before the performance of any protocol related procedures that are not part of normal subject care\r\n* Subjects must be willing and able to comply with scheduled visits, treatment schedule, and laboratory testing
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Patients must sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Michigan Medical Center indicating that they are aware of the investigational aspects of the treatment and the potential risks
Subject or legal representative must understand the investigational nature of this study and sign an Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Understand and voluntarily sign an Institutional Review Board (IRB)-approved informed consent form
Subject or legal representative must understand the investigational nature of this study and sign an independent ethics committee/institutional review board approved written informed consent form prior to receiving any study related procedure
Willing to sign an Institutional Review Board (IRB)-approved informed consent document and adhere to the protocol
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's Regional Ethics Board/Independent Ethics Committee (REB/IEC)
Understand and voluntarily sign an Institutional Review Board (IRB) approved informed consent form
Signed and dated institutional review board (IRB)-approved informed consent before any protocol-specific screening procedures are performed.
Has read, understood and signed the informed consent form (ICF) approved by the Independent Review Board/Independent Ethics Committee (IRB/IEC); and
Subjects must have signed and dated an Institutional Review Board/Independent Ethics Committee (IBR/IEC) approved written informed consent form in accordance with regulatory and institutional guidelines
Signed and dated Institutional Review Board (IRB)-approved consent form
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure. Expansion part:
Provide written informed consent for study participation, approved by the appropriate institutional review board (IRB), and be willing and able to cooperate with all aspects of the protocol;
Subject is capable of understanding and complying with parameters as outlined in the protocol and able to sign and date the informed consents, approved by the Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
Sign an Institutional Review Board (IRB)-approved informed consent document
Patients must have signed and dated an Institutional Review Board/Independent Ethics Committee -approved written informed consent form in accordance with regulatory and institutional guidelines. This must be obtained before the performance of any protocol-related procedures that are not part of normal patient care
Written informed consent on an Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved ICF before any study-specific evaluation
Prospective study participants must be informed of the investigational nature of the study and must have signed an Institutional Review Board (IRB)-approved informed consent form in accordance with institutional and federal guidelines
Patients or their legal representative must be able to read (or have read to them), understand, and sign a written informed consent (approved by the institutional review board) within 14 days prior to start of treatment.
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Understanding and voluntary signing an Institutional Review Board (IRB)-approved informed consent form
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Fully informed about their illness and the investigational nature of the study protocol and must sign and date an Institutional Review Board-approved Informed Consent Form
Absence of signed and dated Institutional Review Board-approved patient informed consent from prior to enrollment in the study
Able to understand and willing to sign an institutional review board (IRB)-approved informed consent document
Patient (or legally authorized representative if applicable) must be able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Be able and willing to sign informed consent document that has been approved by an institutional review board or independent ethics committee (IRB/IEC)
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Subject must be capable of understanding and complying with parameters as outlined in the protocol and able to sign informed consent, approved by an Institutional Review Board (IRB) prior to the initiation of any screening or study specific procedures.
Must voluntarily sign and date each informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.
Subject must voluntarily sign and date an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
Sign an Institutional Review Board (IRB)-approved informed consent document
Patients must be able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Sign an Institutional Review Board (IRB)-approved informed consent document
Ability to read, understand, and sign a written informed consent approved by each Institutional Review Board (IRB); alternatively, patients with legal guardians who can read, understand, and sign written informed consent may also enroll
Subject is capable of understanding and complying with parameters as outlined in the protocol and the subject or the subject's legal acceptable representative is able to sign informed consent, approved by an Institutional Review Board (IRB) prior to the initiation of any or study-specific procedures.
Competent to sign and date an Institutional Review Board approved informed consent form
Voluntary signed Institutional Review Board (IRB) approved consent informed before performance of any study-related procedure not part of normal medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care
Patients must have signed the current Institutional Review Board (IRB) approved informed consent prior to registration (see Informed Consent).
Patients must sign an Institutional Review Board (IRB) approved informed consent form for this purpose indicating that they are aware of the investigational aspects of the treatment and the potential risks; they also must be able to understand and the willing to sign a written informed consent
Ability to understand and willingness to sign an Institutional Review Board (IRB), approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Patient or durable power of attorney (DPA) for healthcare must be able to understand and voluntarily sign an Institutional Review Board (IRB)-approved informed consent form
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and the willingness to sign the Institutional Review Board (IRB)-approved informed consent document
Able to understand and willing to sign an institutional review board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Patient or legal representative must understand the investigational nature of this study and sign an Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Institutional Review Board (IRB) approved, signed written informed consent
Signed, Institutional Review Board (IRB)-approved written informed consent
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Able to understand and willing to sign Institutional Review Board (IRB) approved written informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Institutional review board (IRB) approved signed written informed consent
Able to understand and sign an Institutional Review Board (IRB)-approved informed consent form
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Able and willing to sign an Institutional Review Board (IRB)-approved written informed consent
All patients must sign informed consent verifying that they are aware of the investigational nature of this study in keeping with the rules and policies of M.D. Anderson Cancer Center; the only acceptable consent is the one approved by M.D. Anderson Institutional Review Board (IRB)
Signed informed consent approved by the Duke Institutional Review Board
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Signed informed consent approved by the Institutional Review Board prior to patient entry
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document (either directly or via a legally authorized representative)
Institutional Review Board (IRB) approved, signed written informed consent
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Institutional Review Board (IRB) approved signed written informed consent
Ability to understand and the willingness to sign an institutional review board (IRB)-approved informed consent document
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Signed Institutional Review Board (IRB) approved written informed consent
Must be competent and able to comprehend, sign, and date an Ethics Committee (EC) or Institutional Review Board approved Informed Consent Form (ICF) before performance of any study-specific procedures or tests;
Subjects must have signed and dated an institutional review board (IRB) approved written informed consent in accordance with regulatory and institutional guidelines; this must be obtained before the performance of any protocol related procedures that are not part of normal subject care
All patients must sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Pennsylvania
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document
Patient must be able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Patient (or legally authorized representative if applicable) must be able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Signed an Institutional Review Board (IRB)-approved informed consent
Signed written informed consent approved by the Institutional Review Board obtained prior to study entry
All subjects must have the ability to understand and the willingness to sign a written informed consent that has been approved by the City of Hope (COH) Institutional Review Board (IRB); the patient, a family member and transplant staff physician (physician, nurse, and social worker) will meet at least once prior to the subject signing consent; during this meeting all pertinent information with respect to risks and benefits to donor and recipient will be presented; alternative treatment modalities will be discussed; the risks are explained in detail in the enclosed consent form
Patients must sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Michigan Hospital indicating that they are aware of the investigational nature of this MRI, of the potential but minimal risks of these additional scans, and that their treatments may or may not be altered by the results of these scans
The study has been explained to the patient/volunteer and the subject has signed the Institutional Review Board (IRB)-approved informed consent form prior to optical measurements
Subject must understand the investigational nature of this study and sign an Independent Ethics Committee/ Institutional Review Board approved written informed consent form prior to receiving any study related procedure
A signed informed consent form approved by the Duke University Institutional Review Board (IRB) will be required for patient enrollment into the study. Patients or their legally authorized representative (LAR) must be able to read and understand the informed consent document and must sign the informed consent indicating that they are aware of the investigational nature of this study. Treating physicians at the time the protocol is presented are able to determine based on their clinical judgment whether patients lack the capacity and require a LAR to sign the consent form
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document
Able to and provides Institutional Review Board (IRB) approved study specific written informed consent
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Willing and able to understand and sign informed consent form approved by the institutional review board (IRB)
Ability to understand and the willingness to sign a written informed consent document that is approved by the local institutional review board
Subject must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Are able to give written informed consent in a manner approved by the Institutional Review Board and comply with the requirements of the study.
Patient must consent to be in the study and must have signed and dated an Institutional Review Board (IRB) approved consent form conforming to federal and institutional guidelines
Must be able and willing to sign an informed consent approved by the Institutional Review Board (IRB)
The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines
TNBC patients who are previously untreated and enrolled in the prospective Institutional Review Board (IRB) approved clinical trial: 2014-0185
Consent: patients must be able to give written, informed consent as approved by the local Institutional Review Board (IRB)
Informed consent signed by participant, parent, or guardian according to the guidelines of the institutional review board
Must be able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent\r\ndocument
Subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Have read and signed the Institutional Review Board (IRB)-approved informed consent form for participating in the study
Will sign the Institutional Review Board (IRB)-approved consent form
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Women must be enrolled in Atlanta Women’s human immunodeficiency virus (HIV) Interagency Study (WIHS) (institutional review board [IRB] # 00062469)
Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
PATIENT: Have read and signed the Institutional Review Board (IRB)-approved informed consent form for participating in the study
Legally authorized representative/guardian must be able to understand and willing to sign an Institutional Review Board (IRB)-approved informed consent document
Patients must understand and be willing to sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Michigan Medical Center indicating that they are aware of the investigational aspects of the treatment and the potential risks
All patients or their legal guardians (if the patients is < 18 years old) must sign an Institutional Review Board (IRB)-approved document of informed consent to demonstrate their understanding of the investigational nature and the risks of this study before any protocol-related studies are performed; when appropriate, pediatric subjects will be included in all discussions
Written informed consent will be signed by the patients before the MRI based on the guidelines approved by the Ohio State University Institutional Review board
Informed consent signed by participant, parent, or guardian according to the guidelines of the institutional review board
INCLUSION CRITERIA FOR OPEN-ACCESS: Informed consent signed by participant, parent, or guardian according to the guidelines of the institutional review board
Signed, Institutional Review Board (IRB)-approved written informed consent
Subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Participant must be able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Institutional Review Board (IRB) written informed consent obtained and signed
Patients must sign an Institutional Review Board (IRB)-approved informed consent document
Subjects must have signed Institutional Review Board (IRB)-approved informed consent documentation
Subjects must have signed an institutional review board (IRB)-approved informed consent document
Ability to understand and the willingness to sign an institutional review board (IRB)-approved informed consent document
Patients must sign an institutional review board (IRB)-approved informed consent document
Subjects (or their parent or legal guardian) must have signed Institutional Review Board (IRB)-approved assent/informed consent documentation
Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document
Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's Institutional Review Board (IRB)/Ethics Committee
Subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Patient or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
Are fully informed about their illness and the investigational nature of the study protocol (including foreseeable risks and possible side effects) and must sign and date an Institutional Review Board (IRB)-approved informed consent form (ICF), including Health Insurance Portability and Accountability Act authorization, if applicable, before performance of any study-specific procedures or tests
Patient: Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Able to understand and willing to sign an Institutional Review Board (IRB)-approved written informed consent document
Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document (or that of legally authorized representative, if applicable)
Be Institutional Review Board (IRB)-approved and open to accrual at USC Norris
